
HEALTH CATALYST INC
HCATNASDAQTrading Snapshot
- Day Range
- $351.75 β $360.98
- 52-Week Range
- $0.96 β $3.80
- Volume
- $1.82B
- Avg Volume
- $1.32B
- Shares Outstanding
- 73.9M
- Next Earnings
- Oct 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $311M
- Last Q Revenue
- $70M
- P/E Ratio
- β
- P/S Ratio
- 0.4x
- EPS (TTM)
- $-3.68
- Dividend Yield
- β
Why Investors Own HCAT
- βHigh-growth profile β revenue up +14.3% YoY with expanding US Equity exposure.
- βHealthy economics β 53% gross margin and 22% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About HEALTH CATALYST INC
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
HEALTH CATALYST INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift HCAT price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
HEALTH CATALYST INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.